New Delhi (NVI): UK Foreign Secretary Dominic Raab today met Prime Minister Narendra Modi and discussed various bilateral issues including stepping-up collaboration on the Covid-19 vaccine and developing a new virtual UK-India vaccines hub.
In his meeting with PM Modi, the UK Foreign Secretary welcome the UK and India’s collaboration on tackling coronavirus, while discussing a slew of possibilities regarding Covid-19 response between the two countries.
Experts from India and the UK will join forces through a new virtual hub to deliver vaccines for coronavirus and other deadly viruses, the British High Commission said in a statement.
Raab, who is on a three-day visit to India from December 14-17, also visited a Delhi health clinic where Oxford/AstraZeneca vaccines will be administered.
During his meeting with PM Modi, the UK Foreign Secretary discussed the UK and India working together as a force for good and launching the pioneering new vaccines hub, which will share best practice for regulation and clinical trials, and foster innovation, the BHC said.
India’s Serum Institute is poised to make over a billion doses of the coronavirus vaccine developed by Oxford University and AstraZeneca. Unlike other vaccines, it can be stored at normal fridge temperatures, making it easier and cheaper to produce and keep – and distribute around the world.
On the occasion, Foreign Secretary Dominic Raab said: “This Serum Institute and Oxford University partnership demonstrates the UK-India relationship at its best: a vaccine developed in the UK and made in India; drawing our brightest minds together to save lives as a global force for good.
“A global pandemic requires a global solution. Scientific cooperation has made breakthroughs on coronavirus vaccines at record-breaking pace and the UK-India Vaccine Hub will now build on these innovations, to bring this crisis to an end and protect us all against future pandemics,” he said.
Millions of the doses made by the Serum Institute will be distributed to the world’s poorest people via the global COVAX initiative, in partnership with the World Health Organization (WHO) and Gavi, the vaccine alliance.
The UK has championed equitable access to any coronavirus vaccine for those who need it and has committed up to £619 million to COVAX to secure both the UK’s access to coronavirus vaccines and distribute Covid-19 vaccines across the world.
India supplies more than 50% of the world’s vaccines and 25% of the NHS’s generic drugs.
Closer UK-India cooperation on medicines and vaccines approvals will ensure speedy access for the UK to Indian-produced pharmaceuticals and help safeguard future supplies to the NHS, the BHC said in a release.
The new hub will enable British and Indian experts to share knowledge on clinical trials and regulatory approvals and get vaccines to people who need them most in a safe, secure and energy-efficient way.
It will protect the UK and India by enhancing cooperation on the development and distribution of coronavirus vaccines, better aligning the international regulation of vaccines, and fostering partnerships to develop innovation ‘moonshots’ that can define vaccine delivery over the next decade and beyond, BHC said.
During his meeting with Prime Minister Modi today, the Foreign Secretary also signalled his ambition for a closer UK-India relationship as part of a wider UK focus on our partnerships in the Indo-Pacific. They also spoke about the 10-year roadmap which heralds a new era for the UK and India with an ambitious plan for an Enhanced Trade Partnership.
Later today, the Foreign Secretary also met Minister for Education Ramesh Pokhriyal and agreed to work together on mutual recognition of academic qualifications, starting with master’s degrees, over the next year.
The Foreign Secretary welcomed the signing of a new agreement between the University of Edinburgh and the Indian State of Gujarat to open a new biotechnology university in Gujarat in July 2021. This will be the first foreign university collaboration of its kind in India.
